Human studies, utilizing PET and SPECT imaging, indicate decreased D1R and D2R, as well as DA transporters, in the nigrostriatal pathway in AD [149, 176–178], despite unaffected DA synthesis [179]. Here, DRD1 is linked to Alzheimer disease.